Cell Migration and Invasion Assays as Tools for Drug Discovery

Cell migration and invasion are processes that offer rich targets for intervention in key physiologic and pathologic phenomena such as wound healing and cancer metastasis. With the advent of high-throughput and high content imaging systems, there has been a movement towards the use of physiologically relevant cell-based assays earlier in the testing paradigm. This allows more effective identification of lead compounds and recognition of undesirable effects sooner in the drug discovery screening process. This article will review the effective use of several principle formats for studying cell motility: scratch assays, transmembrane assays, microfluidic devices and cell exclusion zone assays.

[1]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[2]  P. Friedl,et al.  The biology of cell locomotion within three-dimensional extracellular matrix , 2000, Cellular and Molecular Life Sciences CMLS.

[3]  Kevin W Eliceiri,et al.  Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. , 2008, Biophysical journal.

[4]  Tracy Worzella,et al.  An Automated High-Content Assay for Tumor Cell Migration through 3-Dimensional Matrices , 2010, Journal of biomolecular screening.

[5]  M. Obara,et al.  The third type III module of human fibronectin mediates cell adhesion and migration. , 2010, Journal of biochemistry.

[6]  T. Mitchison,et al.  Phenotypic screening of small molecule libraries by high throughput cell imaging. , 2003, Combinatorial chemistry & high throughput screening.

[7]  S. Eccles,et al.  Cell migration/invasion assays and their application in cancer drug discovery. , 2005, Biotechnology annual review.

[8]  T. Asahara,et al.  Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. , 2006, Cancer research.

[9]  M. Sheetz,et al.  Two distinct modes of myosin assembly and dynamics during epithelial wound closure , 2007, The Journal of cell biology.

[10]  Olivera Stojadinovic,et al.  PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[11]  S. Zucker,et al.  Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.

[12]  Malcolm W R Reed,et al.  A critical analysis of current in vitro and in vivo angiogenesis assays , 2009, International journal of experimental pathology.

[13]  Jonathan A. Lee,et al.  A Quantitative, Facile, and High-Throughput Image-Based Cell Migration Method Is a Robust Alternative to the Scratch Assay , 2011, Journal of biomolecular screening.

[14]  P. Chavrier,et al.  Collective migration of an epithelial monolayer in response to a model wound , 2007, Proceedings of the National Academy of Sciences.

[15]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[16]  S A Sundberg,et al.  High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.

[17]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[18]  Timothy J Mitchison,et al.  Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. , 2005, Chemistry & biology.

[19]  T. Mitchison,et al.  A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods , 2004, BMC biotechnology.

[20]  John M. Walker,et al.  Cell Migration , 2005, Methods in Molecular Biology™.

[21]  N. Carragher Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover , 2009, Clinical & Experimental Metastasis.

[22]  D. Beebe,et al.  Cell culture models in microfluidic systems. , 2008, Annual review of analytical chemistry.

[23]  Amanda Y. Chan,et al.  Cell migration and invasion assays. , 2005, Methods.

[24]  Takashi Takahashi,et al.  Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. , 2011, European journal of pharmacology.

[25]  Hong Liu,et al.  Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Lee M Ellis,et al.  Regulatory role of c-Met in insulin-like growth factor-I receptor–mediated migration and invasion of human pancreatic carcinoma cells , 2006, Molecular Cancer Therapeutics.

[27]  Craig E. Higgins,et al.  PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes. , 2010, The Journal of investigative dermatology.

[28]  J. Zock,et al.  Applications of High Content Screening in Life Science Research , 2009, Combinatorial chemistry & high throughput screening.

[29]  D. L. Taylor,et al.  Advances in high content screening for drug discovery. , 2003, Assay and drug development technologies.

[30]  Vito Quaranta,et al.  A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro , 2008, BMC Cancer.

[31]  E. Blackburn,et al.  Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility. , 2010, Endocrine-related cancer.

[32]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[33]  Joachim Wegener,et al.  Electrical wound-healing assay for cells in vitro. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Ogasawara,et al.  Screening of natural compounds for inhibitory activity on colon cancer cell migration. , 2001, Biological & pharmaceutical bulletin.

[35]  Jae Heun Lee,et al.  Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[37]  P. Friedl,et al.  Collective cell migration in morphogenesis and cancer. , 2004, The International journal of developmental biology.

[38]  T. Ludwig,et al.  Evaluation of head and neck squamous cell carcinoma invasiveness by the electrical resistance breakdown assay , 2005, Clinical & Experimental Metastasis.

[39]  H. Sorg,et al.  Wound Repair and Regeneration , 2012, European Surgical Research.

[40]  Anastasia Khvorova,et al.  Identification of genes that regulate epithelial cell migration using an siRNA screening approach , 2008, Nature Cell Biology.

[41]  John S. Condeelis,et al.  ROCK- and Myosin-Dependent Matrix Deformation Enables Protease-Independent Tumor-Cell Invasion In Vivo , 2006, Current Biology.

[42]  A. Kolokythas,et al.  Downregulation of the Rho GTPase signaling pathway is involved in the microRNA‐138‐mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma , 2010, International journal of cancer.

[43]  Seung-Oe Lim,et al.  p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma , 2010, FEBS letters.

[44]  M. Labow,et al.  A Quantitative High-Throughput Endothelial Cell Migration Assay , 2004, Drug discovery today.

[45]  Robin A Felder,et al.  3D cell culture opens new dimensions in cell-based assays. , 2009, Drug discovery today.

[46]  Glenn D Prestwich,et al.  Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. , 2008, Accounts of chemical research.

[47]  S. Zahler,et al.  Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis , 2010, BMC Cancer.

[48]  Erik Sahai,et al.  Mechanisms of cancer cell invasion. , 2005, Current opinion in genetics & development.

[49]  G. Neufeld,et al.  A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion , 2009, BMC Cancer.

[50]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[51]  J. Garcia,et al.  Protein Kinase C-ϵ Regulates Sphingosine 1-Phosphate-mediated Migration of Human Lung Endothelial Cells through Activation of Phospholipase D2, Protein Kinase C-ζ, and Rac1* , 2008, Journal of Biological Chemistry.

[52]  I. Mian,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[53]  E. Sahai,et al.  LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells , 2010, The Journal of cell biology.

[54]  S. Boyden THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTES , 1962, The Journal of experimental medicine.